🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/10/2011 | 30,00 | 30,31 | 29,59 | 30,02 | +0,35% | 2,42% | 26.487.152 |
| 04/10/2011 | 29,84 | 30,00 | 29,14 | 29,91 | -0,70% | 2,88% | 30.077.600 |
| 03/10/2011 | 31,10 | 31,22 | 30,11 | 30,12 | -3,46% | 3,56% | 24.962.941 |
| 30/09/2011 | 30,92 | 31,79 | 30,87 | 31,20 | +0,12% | 2,99% | 25.393.250 |
| 29/09/2011 | 30,87 | 31,32 | 30,74 | 31,16 | +2,25% | 1,85% | 20.233.526 |
| 28/09/2011 | 30,86 | 31,18 | 30,42 | 30,48 | -0,62% | 2,47% | 15.477.598 |
| 27/09/2011 | 30,56 | 31,01 | 30,49 | 30,67 | +1,68% | 1,72% | 15.967.642 |
| 26/09/2011 | 29,84 | 30,24 | 29,59 | 30,16 | +1,80% | 2,17% | 16.230.481 |
| 23/09/2011 | 29,50 | 29,80 | 29,30 | 29,63 | -0,26% | 1,68% | 19.813.593 |
| 22/09/2011 | 29,75 | 30,04 | 29,36 | 29,70 | -2,26% | 2,28% | 24.532.213 |
| 21/09/2011 | 31,17 | 31,40 | 30,36 | 30,39 | -2,00% | 3,34% | 15.321.131 |
| 20/09/2011 | 30,74 | 31,33 | 30,69 | 31,01 | +0,78% | 2,08% | 14.426.454 |
| 19/09/2011 | 30,63 | 30,87 | 30,44 | 30,77 | -1,32% | 1,40% | 13.971.202 |
| 16/09/2011 | 31,18 | 31,30 | 30,95 | 31,18 | +0,58% | 1,10% | 20.506.426 |
| 15/09/2011 | 30,91 | 31,01 | 30,56 | 31,00 | +1,15% | 1,45% | 13.376.567 |
| 14/09/2011 | 30,48 | 30,96 | 30,04 | 30,65 | +1,20% | 3,04% | 16.398.894 |
| 13/09/2011 | 30,11 | 30,45 | 30,01 | 30,29 | -0,81% | 1,46% | 15.363.470 |
| 12/09/2011 | 30,11 | 30,58 | 29,96 | 30,53 | +0,50% | 2,06% | 15.848.590 |
| 09/09/2011 | 31,11 | 31,11 | 30,16 | 30,38 | -2,87% | 3,04% | 29.058.839 |
| 08/09/2011 | 31,26 | 31,67 | 31,15 | 31,28 | -0,55% | 1,65% | 34.980.354 |
| 07/09/2011 | 31,06 | 31,50 | 31,03 | 31,45 | +2,20% | 1,51% | 14.616.351 |
| 06/09/2011 | 30,18 | 30,82 | 30,07 | 30,77 | -0,37% | 2,50% | 18.298.604 |
| 02/09/2011 | 31,17 | 31,26 | 30,82 | 30,89 | -1,61% | 1,41% | 14.013.018 |
| 01/09/2011 | 31,54 | 31,96 | 31,36 | 31,39 | -0,60% | 1,91% | 13.169.063 |
| 31/08/2011 | 31,44 | 31,78 | 31,39 | 31,58 | +1,22% | 1,24% | 15.088.475 |
| 30/08/2011 | 30,82 | 31,39 | 30,63 | 31,20 | +0,74% | 2,48% | 13.414.086 |
| 29/08/2011 | 30,61 | 31,08 | 30,61 | 30,97 | +1,69% | 1,53% | 12.101.046 |
| 26/08/2011 | 30,15 | 30,59 | 29,56 | 30,46 | +0,19% | 3,42% | 19.337.067 |
| 25/08/2011 | 30,77 | 30,77 | 30,26 | 30,40 | -1,15% | 1,67% | 16.844.294 |
| 24/08/2011 | 30,47 | 30,81 | 30,22 | 30,75 | +0,91% | 1,94% | 14.063.217 |